Search History
Clear
Trending Searches
Refresh
avatar

ZTlido

United States

Company Type: Finished Product Manufacturers

Main products: ZTlido,Lidocaine patch
Expand

Products

Enterprise archives

WHEN PAIN* RELIEF WITH GABAPENTINOIDS ISN’T ENOUGH1 Find the perfect partner in ZTlido® ADDING ZTlido DOUBLES PAIN RELIEF1 — WITHOUT THE BAGGAGE OF ORAL ANALGESICS2 For patients suffering from chronic neuropathic pain, gabapentinoids typically do not provide enough pain relief1,2 Titration to an effective dose is often unattainable3 Only 14% of gabapentin patients reach the minimally effective dose of 1800 mg/day due to dose-limiting side effects3-10* Takes 10 weeks, on average3 Only 27% of pregabalin patients reach the minimally effective dose of ≥300 mg/day due to dose-limiting side effects3,4,9* Takes 9.2 weeks, on average3 But adding oral analgesics to boost gabapentinoids comes with baggage3,6-7 Patient function and quality of life can be negatively impacted when pain relief is not enough An 8-week trial using up to 3 patches daily, (to ensure adequate coverage of the painful area) is recommended to achieve similar results1 ZTlido is indicated for relief of pain associated with post-herpetic neuralgia (PHN) in adults. ZTLIDO is contraindicated in patients with a known history of sensitivity to local anesthetics of the amide type, or to any other component of the product. Side effects of ZTlido include application site reactions such as irritation, erythema, and pruritus.

Business Information
  • Unified Social Credit Code
  • Company Legal Person
  • Registered Capital
  • Established
  • Registered Address
  • Scope Of Business
Foreign Trade Information
Contact details
  • Contact Person SCILEX Pharmaceuticals Inc.
  • Contact Position -
  • Contact Phone 1-86****
  • Email pri****@scilexpharma.com; opt-out@scilexpharma.com
  • Contact Address -
Official Website
  • ztlido.com
Production Strength
  • Annual Output Value
  • Annual Sales
  • Production Base
  • Clients
Product Consultation